Manufacturer record
Cosway Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Cosway Pharmaceuticals were declared Not of Standard Quality between September 2020 and June 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Cosway Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| M2 Pan-DSR (Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP) | CWHC-283Mfg 2022-10 · Exp 2024-09 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION OF PANTOPRAZOLE AT ACID STAGEDissolution | State Lab MaharashtraState lab | Jun 2024 |
| Isopropyl Alcohol, Carbopol, Triethanolamine, Glycerin and Chlorhexidine Digluconate Hand Sanitizer ( Safe And Clean Hand Sanitizer) | C-02Mfg 2020-04 · Exp 2022-03 | Assay of Glycerin, Chlorhexidine DigluconateAssay | RDTL ChandigarhState lab | Sep 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.